Clinical Trial Update: Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating voriconazole as secondary prophylaxis against invasive fungal infections in allogeneic stem cell transplant recipients; results complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Prophylaxis Of Invasive Fungal Infections | Phase 4 | Status: COMPLETED | Results posted: 2009-06-01